Two-dimensional high performance liquid chromatography for determination of homocysteine, methionine and cysteine enantiomers in human serum

Journal of Chromatography A

Volumn 1408, Issue , 2015, Pages 118-124

  Deáková, Zuzana ^a,b   Durăcková, Zdeňkă ^b   Armstrong, Daniel W ^c   Lehotay, Jozef ^a  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

^c UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Amino acids; Chirobiotic TAG; Electrochemical detection; HPLC; Human serum

Indexed keywords

CHEMICAL DETECTION; ENANTIOMERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION; SIGNAL TO NOISE RATIO;

AMINO ACID SEPARATIONS; CHIROBIOTIC TAG; ELECTROCHEMICAL DETECTION; HPLC; HUMAN SERUM; MOBILE-PHASE COMPOSITION; SIGNAL TO NOISE (S/N) RATIOS; TWO-DIMENSIONAL HPLC;

AMINO ACIDS;

BUFFER; CYSTEINE; HOMOCYSTEINE; ION INTERACTION REAGENT; METHIONINE; ORGANIC SOLVENT; REAGENT; UNCLASSIFIED DRUG;

ADULT; AMINO ACID ANALYSIS; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CALIBRATION; CASE REPORT; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; ENANTIOMER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MOBILE PHASE; MULTIPLE SCLEROSIS; PH; PRIORITY JOURNAL; SERUM; SIGNAL NOISE RATIO; YOUNG ADULT; BLOOD; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CHEMISTRY; STEREOISOMERISM;

ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; FEMALE; HOMOCYSTEINE; HUMANS; LIMIT OF DETECTION; MALE; METHIONINE; MULTIPLE SCLEROSIS; SIGNAL-TO-NOISE RATIO; STEREOISOMERISM; YOUNG ADULT;

EID: 84945992713     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2015.07.009     Document Type: Article

References (55)

1. S.P. Stabler, P.D. Marcell, E.R. Podell, R.H. Allen, Quantitation of total homocys-teine, total cysteine, and methionine in normal serum and urine using capillarygas chromatography-mass spectrometry, Anal. Biochem. 162 (1987) 185-196.
2. G. Weaving, B.F. Rocks, S.A. Iversen, M.A. Titheradge, Simultaneous quantita-tion of homocysteine, cysteine and methionine in plasma and urine by liquidchromatography-tandem mass spectrometry, Ann. Clin. Biochem. 43 (2006)474-480.
3. L.M. Taylor, G.L. Moneta, G.J. Sexton, R.A. Schuff, J.M. Porter, Prospective blindedstudy of the relationship between plasma homocysteine and progression ofsymptomatic peripheral arterial disease, J. Vasc. Surg. 29 (1999) 8-19.
4. N. Triantafyllou, M.E. Evangelopoulos, V.K. Kimiskidis, E. Kararizou, F. Boufi-dou, K.N. Fountoulakis, M. Siamouli, Ch. Nikolaou, C. Sfagos, N. Vlaikidis, D. Vassilopoulos, Increased plasma homocysteine levels in patients with multiplesclerosis and depression, Ann. Gen. Psychiatry 7 (2008) 17-21.
5. http://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/basics/definition/con-20026689 (assessed 23.11.14).
6. E.H. Reynolds, Multiple sclerosis and vitamin B12 metabolism, J. Neurol. Neu-rosurg. Psychiatry 55 (1992) 339-340.
7. D.E. Goodkin, D.W. Jacobsen, N. Galvez, M. Daughtry, M. Secic, R. Green, Serumcobalamin deficiency is uncommon in multiple sclerosis, Arch. Neurol. 51(1994) 1110-1114.
8. G.S.M. Ramsaransing, M.R. Fokkema, A. Teelken, A.V. Arutjunyan, M. Koch, J. DeKeyser, Plasma homocysteine levels in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry 77 (2006) 189-192.
9. C.E. Teunissen, J. Killestein, J.J. Kragt, C.H. Polman, C.D. Dijkstra, H.J. Blom, Serumhomocysteine levels in relation to clinical progression in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry 79 (2008) 1349-1353.
10. J. Rio, J. Montalban, M. Tintore, A. Codina, M.R. Malinow, Serum homocysteinelevels in multiple sclerosis, Arch. Neurol. 51 (1994) 1181.
11. D.W. Armstrong, M.P. Gapser, S.H. Lee, J. Zukowski, N. Ercal, d-Amino acid levelsin human physiological fluids, Chirality 5 (1993) 375-378.
12. A. Hashimoto, S. Kumashiro, T. Nishikawa, T. Oka, K. Takahashi, T. Mito, S. Takashima, N. Doi, Y. Mizutani, T. Yamazaki, Embryonic development and post-natal changes in free d-aspartate and d-serine in the human prefrontal cortex, J. Neurochem. 61 (1993) 348-351.
13. S.A. Fuchs, R. Berger, L.W.J. Klomp, T.J. de Koning, d-Amino acids in the centralnervous system in health and disease, Mol. Genet. Metab. 85 (2005) 168-180.
14. G.H. Fisher, L. Petrucelli, C. Gardner, C. Emory, W.H. Frey, L. Amaducci, S. Sorbi, G. Sorrentino, M. Borghi, A. D'Aniello, Free d-amino acids in human cerebrospinalfluid of Alzheimer disease, multiple sclerosis and healthy control subjects, Mol, Chem. Neuropathol. 23 (1994) 115-124.
15. A. D'Aniello, J.M. Lee, L. Petrucelli, M.M. Di Fiore, Regional decreases of freed-aspartate levels in Alzheimer's disease, Neurosci. Lett. 250 (1998) 131-134.
16. G.H. Fisher, A. D'Aniello, A. Vetere, L. Padula, G.P. Cusano, E.H. Man, Free d-aspartate and d-alanine in normal and Alzheimer brain, Brain Res. Bull. 26(1991) 983-985.
17. H. Bruckner, M. Hausch, Gas chromatographic characterization of free d-aminoacids in the blood serum of patients with renal disorders and of healthy volun-teers, J. Chromatogr. 614 (1993) 7-17.
18. Y. Nagata, R. Masui, T. Akino, The presence of free d-serine, d-alanine and d-proline in human plasma, Experientia 48 (1992) 986-988.
19. H. Bruckner, A. Schieber, Determination of amino acid enantiomers in humanurine and blood serum by gas chromatography-mass spectrometry, Biomed. Chromatogr. 15 (2001) 166-172.
20. M.L. Chouinard, D. Gaitan, P.L. Wood, Presence of the N-methyl-d-aspartate-associated glycine receptor agonist, d-serine, in human temporal cortex:comparison of normal, Parkinson, and Alzheimer tissues, J. Neurochem. 61(1993) 1561-1564.
21. W.F. Visser, N.M. Verhoeven-Duif, R. Ophoff, S. Bakker, L.W. Klomp, R. Berger, T.J. de Koning, A sensitive and simple ultra-high-performance-liquidchromatography-tandem mass spectrometry based method for the quantifi-cation of d-amino acids in body fluids, J. Chromatogr. A 1218 (2011) 7130-7136.
22. Y. Miyoshi, K. Hamase, Y. Tojo, M. Mita, R. Konno, K. Zaitsu, Determination of d-serine and d-alanine in the tissues and physiological fluids of mice with variousd-amino-acid oxidase activities using two-dimensional high-performance liq-uid chromatography with fluorescence detection, J. Chromatogr. B 877 (2009)2506-2512.
23. S.L. Grant, Y. Shulman, P. Tibbo, D.R. Hampson, G.B. Baker, Determina-tion of d-serine and related neuroactive amino acids in human plasma byhigh-performance liquid chromatography with fluorimetric detection, J. Chro-matogr. B 844 (2006) 278-282.
24. D. Koval, J. Jiraskova, K. Strisovsky, J. Konvalinka, V. Kasicka, Capillary elec-trophoresis method for determination of d-serine and its application formonitoring of serine racemase activity, Electrophoresis 27 (2006) 2558-2566.
25. S.T. Li, Q.L. Yu, X. Lu, S.L. Zhao, Determination of d, l-serine in midbrain of Parkin-son's disease mouse by capillary electrophoresis with in-column light-emittingdiode induced fluorescence detection, J. Sep. Sci. 32 (2009) 282-287.
26. N.S. Singh, R.K. Paul, M. Sichler, R. Moaddel, M. Bernier, I.W. Wainer, Capillaryelectrophoresis-laser-induced fluorescence (CE-LIF) assay for measurement ofintracellular d-serine and serine racemase activity, Anal. Biochem. 421 (2012)460-466.
27. G. Thorsén, J. Bergquist, Chiral separation of amino acids in biological fluidsby micellar electrokinetic chromatography with laser-induced fluorescencedetection, J. Chromatogr. B 745 (2000) 389-397.
28. D.W. Armstrong, J.D. Duncan, S.H. Lee, Evaluation of d-amino acid levels inhuman urine and in commercial l-amino acid samples, Amino Acids 1 (1991)97-106.
29. I. Fradi, A.C. Servai, C. Lamalle, M. Kallei, M. Abidi, J. Crommen, M. Fillet, Chemo and enantioselective method for the analysis of amino acids by capillaryelectrophoresis with incapillary derivatization, J. Chromatogr. A 1267 (2012)126-131.
30. J. Yongzhu, K. Hirose, T. Nakamura, R. Nishioka, T. Ueshige, Y. Tobe, Prepara-tion and evaluation of a chiral stationary phase covalently bound with a chiralpseudo-18-crown-6 ether having a phenolic hydroxy group for enantiomerseparation of amino compounds, J. Chromatogr. A 1129 (2006) 201-207.
31. M.H. Hyun, J.S. Jin, W. Lee, Liquid chromatographic resolution of racemic aminoacids and their derivatives on a new chiral stationare phase based on crownether, J. Chromatogr. A (822) (1998) 155-161.
32. M.H. Hyun, S. Ch. Han, B.H. Lipshutz, Y.J. Shin, C.H.J. Welch, New chiral crownether stationary phase for the liquid chromatographic resolution of α-aminoacid enantiomers, J. Chromatogr. A (910) (2001) 359-365.
33. I.J. Kim, S.J. Park, H.J. Kim, Chiral separation of homocysteine by derivatizationwith 4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole followed by capillaryelectrophoresis using γ-cyclodextrin, J. Chromatogr. A (877) (2000) 217-223.
34. Y.K. Ye, B.S. Lord, L. Yin, R.W. Stringham, Enantioseparation of amino acids ona polysaccharide-based chiral stationary phase, J. Chromatogr. A 945 (2002)147-159.
35. A. Berthod, U.B. Nair, Ch. Bagwill, D.W. Armstrong, Derivatized vancomycinstationary phases for LC chiral separations, Talanta 43 (1996) 1767-1782.
36. D.W. Armstrong, Y. Tang, S. Chen, Y. Zhou, Ch. Bagwill, J.R. Chen, Macrocyclicantibiotics as a new class of chiral selectors for liquid chromatography, Anal. Chem. 66 (1994) 1473-1484.
37. A. Berthod, B.L. He, T.E. Beesley, Temperature and enantioseparation by macro-cyclic glycopeptide chiral stationary phases, J. Chromatogr. A 1060 (2004)205-214.
38. A. Berthod, Chiral recognition mechanisms with macrocyclic glycopeptideselectors, Chirality 21 (2009) 167-175.
39. A.S. Astec, Chirobiotic Handbook: A Guide to Using Macrocyclic GlycopeptideBonded Phases for Chiral Separations, 5th ed., Advanced Separation Technolo-gies Inc., USA, 2004, http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/GeneralInformation/chirobiotichandbook. Par.0001.File.tmp/chirobiotichandbook.pdf (accessed 12.12.13).
40. F.G. Sánchez, A.N. Díaz, E.S. Torreño, A. Aguilar, I.M. Lama, M. Algarra, Deter-mination of enantiomeric excess by chiral liquid chromatography withoutenantiomerically pure starting standards, Biomed. Chromatogr. 26 (2012)1241-1246.
41. L. Kuračka, T. Kalnovičová, J. Kucharská, P. Turčáni, Multiple sclerosis: evalua-tion of purine nucleotide metabolism in central nervous system in associationwith serum levels of selected fat-soluble antioxidants, Mult. Scler. Int. 2014(2014) 1-9.
42. I. Garaiova, J. Muchová, Z. Nagyová, C. Mišl'anová, S. Oravec, A. Dukát, D. Wang, S.F. Plummer, Z.Ďuračková, Effect of a plant sterol, fish oil and B vitamin com-bination on cardiovascular risk factors in hypercholesterolemic children andadolescents: a pilot study, Nutr. J. 12 (2013) 1-8.
43. A. Khan, M.I. Khan, Z. Igbal, Y. Shah, L. Ahmad, S. Nazir, D.G. Watson, J.A. Khan, F. Nasir, A. Khan, Ismail, A new HPLC method for the simultaneous determina-tion of ascorbic acid and aminothiols in human plasma and erythrocytes usingelectrochemical detection, Talanta 84 (2011) 789-801.
44. A. Pappa-Louisi, F. Zougrou, The role of mobile-phase ph in the determination ofcatecholamine-related compounds by reversed-phase liquid chromatographywith amperometric detection, Chromatographia 44 (1997) 348-354.
45. S. Melnyk, M. Pogribna, I. Pogribny, R.J. Hine, S.J. James, A new HPLC methodfor the simultaneous determination of oxidized and reduced plasma aminoth-iols using coulometric electrochemical detection, J. Nutr. Biochem. 10 (1999)490-497.
46. Z. Zhu, Z.Y. He, H.N. Liu, Meta-analysis of the relationship between homocys-teine, vitamin B12, folate, and multiple sclerosis, J. Clin. Neurosci. 18 (2011)933-938.
47. S. Zoccolella, C. Tortorella, P. Iaffaldano, V. Direnzo, M. D'Onghia, D. Paoli-celli, P. Livrea, M. Trojano, Elevated plasma homocysteine levels in patientswith multiple sclerosis are associated with male gender, J. Neurol. 259 (2012)2105-2110.
48. M.P. Mattson, T.B. Shea, Folate and homocysteine metabolism in neural plas-ticity and neurodegenerative disorders, Trends Neurosci. 26 (2003) 137-146.
49. L. Tjattas, D.O. Ortiz, S. Dhivant, K. Mitton, E. Rogers, T.B. Shea, Folate deficiencyand homocysteine induce toxicity in cultured dorsal root ganglion neurons viacytosolic calcium accumulation, Aging Cell 3 (2004) 71-76.
50. R. Obeid, W. Herrmann, Mechanisms of homocysteine neurotoxicity in neu-rodegenerative diseases with special reference to dementia, FEBS Lett. 580(2006) 2994-3005.
51. G.R. Moore, Current concepts in the neuropathology and pathogenesis of mul-tiple sclerosis, Can. J. Neurol. Sci. 37 (2010) 5-15.
52. P. Klivényi, K. Kékesi, G. Juhász, L. Vécsei, Amino acid concentrations in cere-brospinal fluid of patients with multiple sclerosis, Acta Neurol. Scand. 95 (1997)96-98.
53. M. Gårseth, L.R. White, J. Aasly, Little change in cerebrospinal fluid amino acidsin subtypes of multiple sclerosis compared with acute polyradiculoneuropathy, Neurochem. Int. 39 (2001) 111-115.
54. M. van Sande, Y. Mardens, K. Adriaenssens, A. Lowenthal, The free amino acidsin human CSF, J. Neurochem. 17 (1970) 125-135.
55. B. Regland, L. Abrahamsson, K. Blennow, B. Grenfeldt, C.G. Gottfries, CSF-methionine is elevated in psychotic patients, J. Neural Transm. 111 (2004)631-640.